Company Info
Phone(248) 957-9024
Year Established
2002
Ticker
OCUP
Exchange
NASDAQ
Contacts
Ben Yerxa, PhDPresident & CEO
Charlie Hoffmann, M.B.A.
Senior VP, Corporate Development & Operations
Joseph Schachle, MBA
COO
Nirav Jhaveri, C.F.A, M.B.A.
CFO
Ash Jayagopal, Ph.D., M.B.A.
CSO & CDO
Company Description
Opus Genetucs, formerly Ocuphire Pharma, is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders.